What's in Triple Hair Inc's pipeline?

Triple Hair Inc has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Triple Hair Inc's portfolio?

Top competitors by shared drug class: Allergan, Aragon Pharmaceuticals, Inc., Arvinas Androgen Receptor, Inc., Astellas Pharma, Astellas Pharma Inc.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/triple-hair-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Triple Hair Inc — Portfolio Competitive Intelligence Brief

Triple Hair Inc pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Minoxidil 5% Topical Solution	Minoxidil 5% Topical Solution	marketed	Potassium channel opener	ATP-sensitive potassium channels (KATP)	Dermatology
TH07	TH07	phase 3	Androgen receptor inhibitor	Androgen receptor	Oncology

Therapeutic area mix

Dermatology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
Aragon Pharmaceuticals, Inc. · 1 shared drug class
Arvinas Androgen Receptor, Inc. · 1 shared drug class
Astellas Pharma · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
AstraZeneca · 1 shared drug class
Cardurion Pharmaceuticals, Inc. · 1 shared drug class
City of Hope Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Triple Hair Inc:

Cite this brief

Drug Landscape (2026). Triple Hair Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/triple-hair-inc. Accessed 2026-05-16.